Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,299
Total Claims
$996K
Drug Cost
689
Beneficiaries
$1,445
Cost/Patient
Risk Score Breakdown 6/100
Score components are additive. Read full methodology
Peer Comparison vs. 7,389 General Practice providers
+28%
Cost per patient vs peers
$1,445 vs $1,128 avg
+26%
Brand preference vs peers
10.6% vs 8.4% avg
Brand vs Generic
Brand: 1,177 claims · $794K
Generic: 9,940 claims · $191K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 116 | $139K |
| Dulaglutide | 45 | $67K |
| Semaglutide | 49 | $64K |
| Apixaban | 49 | $60K |
| Mirabegron | 59 | $49K |
| Sacubitril/Valsartan | 22 | $37K |
| Empagliflozin | 19 | $30K |
| Sitagliptin Phosphate | 26 | $24K |
| Budesonide/Formoterol Fumarate | 36 | $22K |
| Insulin Glargine,hum.Rec.Anlog | 47 | $19K |
| Rivaroxaban | 17 | $17K |
| Insulin Detemir | 14 | $17K |
| Insulin Nph Hum/Reg Insulin Hm | 20 | $14K |
| Atorvastatin Calcium | 888 | $14K |
| Fluticasone Propionate | 34 | $12K |
Prescribing Profile
Patient Profile
73
Avg Age
62%
Female
1.99
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data